Orsula V.  Knowlton net worth and biography

Orsula Knowlton Biography and Net Worth

Dr. Orsula Voltis Knowlton brings 25 years of entrepreneurial pharmacist, business executive, and innovation experience to TRHC.  During her tenure, she has supported the Company from start-up to market leader in the Program of All-inclusive Care for the Elderly (PACE) market.  Her background includes experience in the pharmaceutical industry, as well as in community, long-term care, hospice and hospital pharmacy.

Prior to TRHC, from 1995 through 2007, Dr. Knowlton was a key member of the start-up management and leadership team of excelleRx, a hospice medication management and pharmacy distribution company. During her tenure as vice president and chief marketing, strategy, and business development officer, the company grew organically to service over 85,000 hospice patients in 49 States. The company was purchased by a Fortune 500 company in 2005.

Recognized for her accomplishments, Dr. Knowlton received the CEO Report 2018 ‘Women’s Leadership’ award, the 2016 ‘Citizen of the Year’ award from the Garden State Council Chapter of the Boy Scouts of America, and the 2016 ‘Community Partner of the Year’ award from the Development Center of Southern New Jersey. She was inducted into the College of Physicians of Philadelphia as a Fellow in 2018.

Dr. Knowlton also is active in her community, serving on the Board of Trustees for Samaritan Hospice and Healthcare in New Jersey and Florida’s Nassau County Board on Aging.

Dr. Knowlton is passionate about supporting women in leadership.  She is a member of Women’s Business Leaders of the U.S. HealthCare Foundation, serving on its Strategy Advisory Board. She was recognized by the Forum of Executive Women and PwC in 2019 and 2020 as a “Champion of Board Diversity” for her influence in diversifying the TRHC Board of Directors to 56% women.

Dr. Knowlton received her Bachelor of Science in Pharmacy and Doctorate in Pharmacy from the University of the Sciences College of Pharmacy in Philadelphia. She is a graduate of Temple University’s Fox School of Business Executive MBA program, also in Philadelphia.

What is Orsula V. Knowlton's net worth?

The estimated net worth of Orsula V. Knowlton is at least $8.96 million as of April 19th, 2021. Dr. Knowlton owns 853,360 shares of Tabula Rasa HealthCare stock worth more than $8,960,280 as of April 25th. This net worth estimate does not reflect any other assets that Dr. Knowlton may own. Learn More about Orsula V. Knowlton's net worth.

How do I contact Orsula V. Knowlton?

The corporate mailing address for Dr. Knowlton and other Tabula Rasa HealthCare executives is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. Tabula Rasa HealthCare can also be reached via phone at (866) 648-2767 and via email at [email protected]. Learn More on Orsula V. Knowlton's contact information.

Has Orsula V. Knowlton been buying or selling shares of Tabula Rasa HealthCare?

Orsula V. Knowlton has not been actively trading shares of Tabula Rasa HealthCare over the course of the past ninety days. Learn More on Orsula V. Knowlton's trading history.

Who are Tabula Rasa HealthCare's active insiders?

Tabula Rasa HealthCare's insider roster includes Brian Adams (CFO), Samira Beckwith (Director), Jan Berger (Director), Michael Greenhalgh (COO), Dennis Helling (Director), Calvin Knowlton (CEO), Orsula Knowlton (President), Andrea Speers (CAO), and A. Tunstall (Director). Learn More on Tabula Rasa HealthCare's active insiders.

Orsula V. Knowlton Insider Trading History at Tabula Rasa HealthCare

See Full Table

Orsula V. Knowlton Buying and Selling Activity at Tabula Rasa HealthCare

This chart shows Orsula V. Knowlton's buying and selling at Tabula Rasa HealthCare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tabula Rasa HealthCare Company Overview

Tabula Rasa HealthCare logo
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. As of December 31, 2022, it served approximately 150 healthcare organizations. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey. As of November 3, 2023, Tabula Rasa HealthCare, Inc. operates as a subsidiary of Exact Care Pharmacy, LLC.
Read More

Today's Range

Now: $10.50
Low: $10.50
High: $10.50

50 Day Range

MA: $10.45
Low: $10.37
High: $10.50

2 Week Range

Now: $10.50
Low: $3.15
High: $10.50

Volume

N/A

Average Volume

225,500 shs

Market Capitalization

$284.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57